Skip to content
Toggle navigation
Home
About
About NFTC
NFTC History
Board of Directors
NFTC Leadership & Staff
Our Projects
Issues
International Tax
International Trade Overview
International Trade Issues
The Vital Role of America’s Digital Trade Leadership
National Security Policy
Supply Chain Policy Overview
Supply Chain Policies
News & Insights
Events
Contact
Contact Us
Membership Inquiries
Career Opportunities
News & Insights
Featured
Public Comments & Letters
NFTC Recommendations for Regulatory Guidance on the One Big Beautiful Bill Act
10/01/25
Read More →
Public Comments & Letters
NFTC Comments on 2025 Draft List of Critical Minerals
09/24/25
Read More →
Public Comments & Letters
NFTC Comments for Consultation on the EU’s Digital Markets Act
09/24/25
Read More →
Public Comments & Letters
NFTC Comments on Australia Software Directive
09/17/25
Read More →
Public Comments & Letters
Multi-Association Letter on Sec. 232 Steel and Aluminum “Inclusions Process”
09/16/25
Read More →
Filter by:
Reset
Press Releases and Statements
NFTC Urges Administration to Double-Down on Dealmaking in the Wake of Court’s Decision on Tariffs
05/29/25
Read More →
Press Releases and Statements
NFTC Statement Following Passage of Reconciliation Bill
05/22/25
Read More →
Press Releases and Statements
NFTC Cautions Against Tariffs on Critical Minerals
05/16/25
Read More →
Press Releases and Statements
NFTC Statement on Release of Reconciliation Bill Tax Text
05/12/25
Read More →
Press Releases and Statements
NFTC Welcomes Progress on China Talks; Urges Continued Work
05/12/25
Read More →
Public Comments & Letters
Multiassociation Letter on the “International Competition for American Jobs Act”
05/12/25
Read More →
Press Releases and Statements
NFTC Statement on U.S.-UK Trade Deal
05/08/25
Read More →
Press Releases and Statements
NFTC Urges “Do No Harm” Approach in Semiconductor 232 Investigation
05/08/25
Read More →
Press Releases and Statements
NFTC Supports Strengthening Pharmaceutical Supply Chains, but Tariffs are not the Answer
05/07/25
Read More →
Public Comments & Letters
NFTC Comments for Sec. 232 Pharmaceutical Investigation
05/07/25
Read More →